Papers - TANAKA Chie
-
Kurimoto K, Hayashi M, Guerrero-Preston R, Koike M, Kanda M, Hirabayashi S, Tanabe H, Takano N, Iwata N, Niwa Y, Takami H, Kobayashi D, Tanaka C, Yamada S, Nakayama G, Sugimoto H, Fujii T, Fujiwara M, Kodera Y
Epigenetics Vol. 12 ( 10 ) page： 865 - 874 2017
-
Prognostic relevance of <i>SAMSN1</i> expression in gastric cancer. Reviewed
Kanda M, Shimizu D, Sueoka S, Nomoto S, Oya H, Takami H, Ezaka K, Hashimoto R, Tanaka Y, Kobayashi D, Tanaka C, Yamada S, Fujii T, Nakayama G, Sugimoto H, Koike M, Fujiwara M, Kodera Y
Oncology letters Vol. 12 ( 6 ) page： 4708-4716 2016.12
-
Epigenetic suppression of the immunoregulator MZB1 is associated with the malignant phenotype of gastric cancer. Reviewed
Kanda M, Tanaka C, Kobayashi D, Tanaka H, Shimizu D, Shibata M, Takami H, Hayashi M, Iwata N, Niwa Y, Yamada S, Fujii T, Nakayama G, Fujiwara M, Kodera Y
International journal of cancer Vol. 139 ( 10 ) page： 2290-8 2016.11
-
Modified two-dimensional response as surrogate marker of overall survival in patients with metastatic colorectal cancer. Reviewed
Nakayama G, Fujii T, Murotani K, Uehara K, Hattori N, Hayashi M, Tanaka C, Kobayashi D, Kanda M, Yamada S, Sugimoto H, Koike M, Fujiwara M, Ando Y, Kodera Y
Cancer science Vol. 107 ( 10 ) page： 1492-1498 2016.10
-
Predictive value of drain amylase content for peripancreatic inflammatory fluid collections after laparoscopic (assisted) distal gastrectomy. Reviewed
Kanda M, Fujiwara M, Tanaka C, Kobayashi D, Iwata N, Mizuno A, Yamada S, Fujii T, Nakayama G, Sugimoto H, Koike M, Kodera Y
Surgical endoscopy Vol. 30 ( 10 ) page： 4353-62 2016.10
-
Protein arginine methyltransferase 5 is associated with malignant phenotype and peritoneal metastasis in gastric cancer. Reviewed
Kanda M, Shimizu D, Fujii T, Tanaka H, Shibata M, Iwata N, Hayashi M, Kobayashi D, Tanaka C, Yamada S, Nakayama G, Sugimoto H, Koike M, Fujiwara M, Kodera Y
International journal of oncology Vol. 49 ( 3 ) page： 1195-202 2016.9
-
Neurotrophin Receptor-Interacting Melanoma Antigen-Encoding Gene Homolog is Associated with Malignant Phenotype of Gastric Cancer. Reviewed
Kanda M, Shimizu D, Fujii T, Tanaka H, Tanaka Y, Ezaka K, Shibata M, Takami H, Hashimoto R, Sueoka S, Iwata N, Kobayashi D, Tanaka C, Yamada S, Nakayama G, Sugimoto H, Koike M, Fujiwara M, Kodera Y
Annals of surgical oncology Vol. 23 ( Suppl 4 ) page： 532-539 2016.8
-
Nutritional predictors for postoperative short-term and long-term outcomes of patients with gastric cancer. Reviewed
Kanda M, Mizuno A, Tanaka C, Kobayashi D, Fujiwara M, Iwata N, Hayashi M, Yamada S, Nakayama G, Fujii T, Sugimoto H, Koike M, Takami H, Niwa Y, Murotani K, Kodera Y
Medicine Vol. 95 ( 24 ) page： e3781 2016.6
-
Tumor Infiltrative Pattern Predicts Sites of Recurrence After Curative Gastrectomy for Stages 2 and 3 Gastric Cancer. Reviewed
Kanda M, Mizuno A, Fujii T, Shimoyama Y, Yamada S, Tanaka C, Kobayashi D, Koike M, Iwata N, Niwa Y, Hayashi M, Takami H, Nakayama G, Sugimoto H, Fujiwara M, Kodera Y
Annals of surgical oncology Vol. 23 ( 6 ) page： 1934-40 2016.6
-
Clinical Implication of Inflammation-Based Prognostic Score in Pancreatic Cancer: Glasgow Prognostic Score Is the Most Reliable Parameter. Reviewed
Yamada S, Fujii T, Yabusaki N, Murotani K, Iwata N, Kanda M, Tanaka C, Nakayama G, Sugimoto H, Koike M, Fujiwara M, Kodera Y
Medicine Vol. 95 ( 18 ) page： e3582 2016.5
-
Metastatic pathway-specific transcriptome analysis identifies MFSD4 as a putative tumor suppressor and biomarker for hepatic metastasis in patients with gastric cancer. Reviewed
Kanda M, Shimizu D, Tanaka H, Shibata M, Iwata N, Hayashi M, Kobayashi D, Tanaka C, Yamada S, Fujii T, Nakayama G, Sugimoto H, Koike M, Fujiwara M, Kodera Y
Oncotarget Vol. 7 ( 12 ) page： 13667-79 2016.3
-
S-1 plus nab-paclitaxel is a promising regimen for pancreatic cancer in a preclinical model. Reviewed
Suenaga M, Yamada S, Fujii T, Tanaka C, Kanda M, Nakayama G, Sugimoto H, Koike M, Fujiwara M, Kodera Y
Journal of surgical oncology Vol. 113 ( 4 ) page： 413-9 2016.3
-
NRAGE promotes the malignant phenotype of hepatocellular carcinoma. Reviewed
Shimizu D, Kanda M, Sugimoto H, Sueoka S, Takami H, Ezaka K, Tanaka Y, Hashimoto R, Okamura Y, Iwata N, Tanaka C, Yamada S, Fujii T, Nakayama G, Koike M, Nomoto S, Fujiwara M, Kodera Y
Oncology letters Vol. 11 ( 3 ) page： 1847-1854 2016.3
-
Short-term outcomes after conventional transthoracic esophagectomy. Reviewed
Niwa Y, Koike M, Hattori M, Iwata N, Takami H, Hayashi M, Kanda M, Kobayashi D, Tanaka C, Yamada S, Fujii T, Nakayama G, Sugimoto H, Nomoto S, Fujiwara M, Kodera Y
Nagoya journal of medical science Vol. 78 ( 1 ) page： 69-78 2016.2
-
Adverse Effects of Intraoperative Blood Loss on Long-Term Outcomes after Curative Gastrectomy of Patients with Stage II/III Gastric Cancer. Reviewed
Mizuno A, Kanda M, Kobayashi D, Tanaka C, Iwata N, Yamada S, Fujii T, Nakayama G, Sugimoto H, Koike M, Fujiwara M, Kodera Y
Digestive surgery Vol. 33 ( 2 ) page： 121-8 2016
-
Current Options for the Diagnosis, Staging and Therapeutic Management of Colorectal Cancer. Reviewed
Nakayama G, Tanaka C, Kodera Y
Gastrointestinal tumors Vol. 1 ( 1 ) page： 25-32 2013.9